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Summary: Methods are described for the analysis of glucose, lactate, pyruvate, alanine, glycerol, 3-hydroxy-
butyrate and acetoacetate in perchloric acid extracts of human blood, using the Cobas Bio centrifugal analyser
fitted with a fluorimetric attachment. Intra-assay and inter-assay coefficients of variation ranged from 1.9 to
7.9% and from 1.0 to 7.2% respectively. Correlation coefficients ranged from 0.96 to 0.99 against established
continuous-flow and manual spectrophotometric methods. All seven metabolites can be measured using a
single perchloric acid extract of 20 μΐ of blood. The versatility of the assays is such that as little as 100 pmol
pyruvate, 3-hydroxybutyrate or as much as 15 nmol glucose can be measured in the same 20 μΐ extract.
In relation to budgetary control the centrifugal analyser methods are quicker, less labour intensive, and more
economical with both small and large numbers of samples.
Introduction
Several automated photometric (1) and fluorimetric
(2 — 5) techniques have been developed to measure
intermediary metabolites. Routinely in our laboratory
blood glucose, lactate, pyruvate, alanine, glycerol and
3-hydroxybutyrate have been measured at room tem-
perature using continuous-flow fluorimetric methods
(6). Up to three different metabolites can be measured
simultaneously in this system. It is relatively simple
and inexpensive to operate and is capable of higher
inter^ and intra-assay precision with large numbers of
easily prepared samples.
A major disadvantage of the continuous-flow meth-
ods is the need of an additional analytical "run" to
assess sample "blanks". Other problems include the
inaccuracies and tedium involved in matching large
numbers of "blank" to "test" fluorescence peaks as
well as measuring them. Alternative systems, which
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might overcome these disadvantages and yet still able
to handle large numbers of samples, were considered.
The most promising appeared to be a centrifugal fast
analyser with a fluorescence detection accessory. A
Cobas Bio with a fluofimeter attachment was ac-
quired, appropriate methods developed and evaluated
in comparison with the corresponding continuous
flow methods. The main advantage of the fluorimetric
centrifugal fast analyser is that the concentration of
all seven metabolites can be reliably determined on a
perchloric acid extract of 20 μΐ of blood.
Materials and Methods
Lithium lactate grade L-X, sodium pyruvate Type II, lithium
acetoacetate and Ζ,-alanine were obtained from Sigma Ltd.
(Poole, Dorset, UK), NAD, NADH, NADP, ATP, £>,JL-3-hy-
droxybutyrate (monosodium salt), lactate dehydrogenase (pig
heart - Cat No 107069), hexokinase (yeast - Cat No 127817),
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L-alanine dehydrogenase (B. subtilis - Cat No 102636), gly-
cerokinase (Candida mycoderma - Cat No 127795), 3-hydroxy-
butyrate dehydrogenase (Rhodopseudomonas spheroides — Cat
No 737054), glycerol-3-phosphate dehydrogenase (rabbit mus-
cle — Cat No 127752) and glucose-6-phosphate dehydrogenase
(yeast - Cat No 127671) from BCL (Lewes, East Sussex, UK)
with glycerol (AR), glucose (50 mmol/1 in saturated i. e. 5 g/1
benzoic acid), perchloric acid - 600 g/kg (AR) and all other
chemicals from BDH (Poole, UK).
Sample preparation
About 1.5—2 ml of whole blood is added to a preweighed
plastic tube containing 5 ml of 0.77 mol/1 perchloric acid pre-
viously cooled to 0 °C. After mixing the tube is reweighed,
centrifuged at 2500 g for 5 min and the protein-free supernatant
removed. The dilution of the blood is determined by the weight
changes measured. Alternatively 0.5 ml whole blood may be
added volumetricaily to 2 ml 0.77 mol/1 perchloric acid and the
weighing omitted. Part of the supernatant is placed in an
Autoanalyzer cup and the remainder stored in another plastic
tube at —20 °C. For the metabolites, other than acetoacetate,
analysis of the samples in the Autoanalyzer cups is carried out
immediately or they are stored at —20 °C. Analysis for aceto-
acetate is carried out immediately or the samples are stored at
-70 °C but for not longer than 3 days.
Continuous flow analyses
These are carried out essentially as described earlier (6) with
0.46 mol/1 perchloric acid used to prepare the standards.
Acetoacetate
A modified manual method for the determination of acetoac-
etate is based on that described by Williamson et al. (7). One
ml of perchloric acid extract is put into a weighed plastic tube
and reweighed. Universal indicator (BDH Cat No 21049) is
added, mixed and the perchloric acid neutralized to a yellow
colour with 3.5 mol/1 and 0.35 mol/1 KOH. The tube is centri-
fuged and re-weighed to determine the dilution of the original
sample. The supernatant is used for analysis. To determine the
acetoacetate content, 500 μΐ of the neutralized extract is added
to 1 ml of 0.42 mmol/1 NADH in 0.1 mol/1 potassium phosphate
buffer, pH 7.0, and 500 μΐ water. The absorbance is measured
against a blank containing 0.21 mmol/1 NADH immediately at
340 nm using a Zeiss PMQ3/MQ/3 spectrophotometer (Carl
Zeiss, Woodfield Road, Welwyn Garden City, Herts., UK) and
again at 30 min, at room temperature, after adding 300 mU of
3-hydroxybutyrate dehydrogenase to determine the decrease.
Blanks are also prepared omitting the neutralized perchloric
acid extract to determine enzyme interaction with the buffered
coenzyme reagent. The acetoacetate content is calculated using
the molar lineic absorbance of NADH of 622 m2/mol. Stand-
ards are prepared using solutions of acetoacetate in 0.46 mol/1
perchloric acid over the range of 25 — 100 μιηόΐ/ΐ which are
treated in the same way as the perchloric acid extracts.
Centrifugal analyser
The instrument used is a Cobas Bio (Roche Products Ltd.,
Welwyn Garden City, UK). All the analysis program parame-
ters are shown in table 1. The assays for alanine, glycerol and
3-hydroxybutyrate were initial rate methods, those for aceto-
acetate and pyruvate end-point methods and those for glucose
and lactate two-point analyses using the instruments own curve-
fitting programme for appropriate standards. The buffers used
are the same as for the continuous-flow methods for the me-
tabolites other than acetoacetate. Modifications, however, are
made in the composition of the coenzyme/enzyme reagents as
follows:
Acetoacetate
Coenzyme reagent: 500 μΐ 0.75 g/i NADH in 0.3 mol/1 potas-
sium phosphate buffer pH 7.4 is added to 20 ml of the same
buffer.
Enzyme reagent ("start" solution): 200 μΐ 3-hydroxybutyrate
dehydrogenase (7.5 U) is added to 400 μΐ water.
To set PM voltage use water as sample arid! 'a* coenzyme reagent
containing: 650 μΐ 0.75 g/l NADH in 0.3 mol/1 potassium
phosphate buffer pH 7.4 added to 20 ml of the same buffer.
Alanine
Buffer: 0.04 mol/1 TRIS, 1 mol/1 hydrazine hydrate, 1.34 mmol/1
EDTA (disodium salt) adjusted to pH 10.0 with 10 mol/1 hy-
drochloric acid.
Enzyme reagent: 20 rng NAD and 100 μΐ alanine dehydrpgenase
(12 U) in 10 ml 0.1 mol/1 phosphate buffer pH 7.4. The working
reagent is prepared by adding 0.7 ml of this solution to 8.8 ml
of the buffer. This dilution is freshly prepared for each batch
of analyses and is warmed to 25 °C before use.
To set PM voltage use top standard (300 μιηρί/ΐ).
Glucose
Buffer: 0.1 mol/1 triethanolamine, 2 inmol/l magnesium chlo-
ride, adjusted to pH 8.0 with 10 mot/1 hydrochloric acid.
Enzyme reagent: 32 mg NADP, 37 mg ATP (disodium salt),
100 μΐ hexokinase (140 U) and 100 μΐ glucose-6-phosphate
dehydrogenase (70 ) in 10 nil 0.4 mol/1 triethanolamine buffer,
pH 7.4.
To set PM voltage use top standard (3 mmol/1).
Glycerol
Buffer: 0.2 mol/1 glycine, 1 mol/1 hydrazine hydrate, 10 mmol/1
magnesium chloride brought to pH 9.5 with 10 mol/1 sodium
hydroxide.
Enzyme reagent: 20 mg NAD, 20 mg ATP (disodium salt), 50
μΐ glycerokinase (21.3U) and 100 μΐ glycerol-3-phosphate de-
hydrogenase (170 U) in 10 ml 0.4 mol/1 triethanolamine buffer,
pH 7.4; 0.7 ml of this reagent added to 8.8 ml of the buffer for
analysis. This mixture is prepared immediately before use and
should be at 25 °C when applied to the analyser.
To set PM voltage use the top standard (120 μιηοΐ/ΐ).
Pyruvate
Buffer: 0.4 mol/1 triethanolammonium chloride, 10 mmol/1 di-
sodium EDTA adjusted to pH 7.4 with 10 mol/1 sodium hy-
droxide.
Coenzyme reagent: 50 μΐ l g/l NADH in 0.1 mol/1 phophate
buffer, pH 7.4 is added to 16 ml of the triethanolamine buffer.
Enzyme reagent ("start" solution): 50 μΐ lactate dehydrogenase
(150 U) is added to 8 ml 0.1 mol/1 phosphate buffer, pH 7.4.
To set PM voltage use water as sample.
Lactate
Buffer: 0.5 mol/1 glycine, 0.2 mol/1 hydrazine hydrochloride,
5.4 mmol/1 disodium EDTA adjusted to pH 9.6 with 10 mol/1
sodium hydroxide.
Enzyme reagent: 50 mg NAD and 500 μΐ lactate dehydrogenase
(1500 L[) in 5 ml 0.1 mol/1 phosphate buffer, pH 7.4.
To set PM voltage use top standard (1.2 rntnol/1).
J. Clin. Chem. Clin. Biochem. / Vol. 26,1988 / No. 3
Harrison et al.r Blood metabolite measurements using a fluorimetric centrifugal analyser 143
Tab. 1. Program parameters for metabolite measurement on the Cobas Bio centrifugal analyser
Aceto-
acetate
Pyruvate Glucose Lactate Alanine Glycerol 3-Hydroxy-
butyrate
Alpha -13 -13 +11 +11 +11 +11 +11
1 . Units 4 4 3 4 4 4 4
2. Calculation factor 0 0 1000 1000 0 0 0
3. Standard 1 cone. 25 10 0.25 50 50 20 20
4. Standard 2 cone. 50 30 1.0 200 150 60 60
5. Standard 3 cone. 100 60 1.5 400 300 120 120
Standard 4 cone. - - 2.0 600 - - -
Standard 5 cone. - — 2.5 900 _ — _
Standard 6 cone. - — 3.0 1200 — _ _
6. Limit 0 70 0 0 0 200 200
7. Temperature, °C 25 25 25 25 25 25 25
8. Assay type 6 6 7.6 7.6 4 4 4
9.* Wavelength, nm 340.2 340.2 340.2 340.2 340.2 340.2 340.2
10. Sample volume, μΐ 20 10 5 5 10 10 20
11. Diluent volume, μΐ 20 10 15 25 20 20 10
12. Reagent volume, μΐ 160 170 200 310 270 270 270
13. Incubation time, s 300 300 300 300 0 0 0
14. Start volume, μΐ 20 10 20 20 0 0 0
1 5 . Reading time, s 1 1 1 1 1 1 1
16. Time interval, s 30 30 30 30 30 30 30
17. Number of readings 18 10 6 20 20 12 20
1 8 . Blanking mode 1 1 1 1 1 1 1
19. Printout mode 1 2 5.1 5.1 2 2 2
PMV 608 736 560 636 752 740 736
All concentrations are in μιηοΐ/ΐ except for glucose which are in mmol/1.
* The excitation wavelength was 340 nm and the emission wavelength was 470 nm. The setting 340.2 identifies that the emission
filter in position No 2 is used.
3-Hydroxybutyrate
Buffer: 0.1 mol/1 TRIS, 1 mol/I hydrazine hydrate, 2.7 mmol/1
EDTA (disodium salt) adjusted to pH 8.5 with 10 mol/1 hydro-
chloric acid.
Enzyme reagent: 10 mg NAD and 350 μΐ 3-hydroxybutyrate
dehydrogenase (7.5 U) in 5 ml 0.1 mol/1 phosphate buffer, pH
7.4. The working reagent is prepared by adding 0.7 ml of this
solution to 8.8 ml of the buffer.
To set PM voltage use top standard (120 μπιοΙ/1).
Standard solutions
Stock standards 100 mmol/1 lithium lactate, 10 mmol/1 sodium
pyruvate, 10 mmol/1 S^hydrpxybutyrate, 100 mmol/1 glycerol,
10 mmol/1 acetoacetate and 250 mmol/1 alanine are prepared
in deionised-distilled water and diluted to the appropriate work-
ing level with 0.46 mol/1 perchloric acid. The glucose standard
is commercially available as 50 mmol/1 in approximately 5 g/1
benzoic acid and is also diluted to the appropriate working
level with the same perchloric acid solution. All standards are
stored in a refrigerator at 4 °C. The working standards shown
in table 1 are in μπιοί/Ι except for glucose which is in mmol/1.
Results
The intra-assay precision for each method was as-
sessed by filling two sample racks, one with a per-
chloric acid extract of blood containing a "low" con-
centration of the metabolite and the other with a
similar extract but with a "high" concentration of the
metabolite. The results are given in table 2.
Tab. 2. Intra- and inter-assay imprecision of analyses
Intra-assay
η = 24
Alanine
3-Hydroxybutyrate
Glycerol
Glucose
Lactate
Pyruvate
Acetoacetate
X
μηιοΐ/ΐ
64
237
12
94
20
100
1100
2500
146
1085
16
47
53
cv
%
2.3
3.0
6.5
2.1
7.9
2.3
2.6
5.4
6.0
6.1
3.5
1.9
5.8
Inter-assay
η = 22
X
μπιοΐ/l
65
239
12
96
20
101
1090
2540
149
979
6
17
—
CV
%
2.7
3.0
4.5
1.0
5.2
3.0
2.8
4.2
6.1
3.7
29.8
6.3
—
Intra-assay variation was carried out in a single run on the
analyser and inter-assay variation over a 3 week period
Inter-assay precision was assessed by measuring two
pooled perchloric acid extracts on separate occasions,
fresh reagents being prepared for each assay. The
results are shown in table 2. Coefficients of variation
ranged from 1.0 to 7.2%.
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The correlations between the results obtained by
Cobas Bio and continuous-flow methods are pre-
sented in table 3. It can be seen that there was a close
correlation for all metabolites with the slope of the
relationship differing significantly from unity only for
acetoacetate and glycerol.
Tab. 3. Correlation of metabolite results obtained with the
Cobas Bio analyser compared with the continuous-flow
analyser.
For the regression line y = bx 4- c the slope and
intercept are also indicated.
Acetoacetate was correlated against a manual spectro-
photometric method.
Alanine
3-Hydroxybutyrate
Glycerol
Glucose
Lactate
Pyruvate
Acetoacetate
No of
ana-
lyses
48
68
69
65
44
44
•26
Correla-
tion coef-
ficient
0.99
0.99
0.96
0.99
0.99
0.99
0.97
Slope of
regres-
sion line
0.96
1.001
0.79
1.03
1.064
1.003
1.02
Intercept
oimol/1)
+ 5.9
- 2.2
+ 3.27
-11.0
-13.2
- 1.25
- 1.2
Discussion
Glucose is the most frequently measured intermediary
metabolite in blood. Other intermediates of carbo-
hydrate metabolism are also of pathophysiological
and clinical interest. Apart from non-esterified fatty
acids the most commonly measured are: lactate, py-
ruvate, 3-hydroxybutyrate, acetoacetate, glycerol and
alanine. The main need to measure these metabolites
currently comes from researchers seeking better un-
derstanding of diabetes and other metabolic disorders.
There are many methods available to measure these
metabolites. Nearly all are enzymatic and have been
shown to be rapid, sensitive and accurate. In some of
those described a number of very similar assays are
grouped together to measure several metabolites (5,
8 — 11). Keintsch-Engel et al. describe a linked method
for the ketone bodies, 3-hydroxybutyrate and aceto-
acetate (12). Others measure glycerol (13) and alanine
(14) singly as indicators of lipolysis and gluconeoge-
nesis from amino acids respectively. Isotope dilution
offers advantages when special sampling techniques
are required to measure glycerol (15), in contrast to
the lack of sample preparation required to measure
glucose (16) and lactate (17) by the use of enzyme
electrodes.
Any advance in instrumentation tends to be applied
to the measurement of metabolites. Recent examples
include bioluminescence-linked methods for the meas-
urement of glycerol (18). However, there is no best
possible method because a variety of criteria, other
than accuracy, must be considered before a method
is chosen. The continuous-flow methods (6) which we
have used previously have certain attributes which
taken together make them very useful. The advan-
tages include: the ability to handle large numbers of
samples by automation, measurement of a variety of
metabolites simultaneously, on the same sample by
similar methods, as well as the usual requirements of
precision and specificity.
The methods we have developed for the centrifugal
analyser were designed to give comparable results and
needed to be at least, as precise as the continuous-
flow methods. Efforts were primarily directed to pro-
duce economical and quick, rather than optimised
methods and thus initial-rate rather than end-point
or two-point, methods were chosen. We have previ-
ously commented on the problem of using perchloric
acid extracts of blood (19). Perchloric acid interferes
with enzymatic assays particularly initial rate meth-
ods. In the methods described here the small volume
of perchloric acid extract used as sample reduces the
concentration of perchloric acid within the assay to
within the range 7 to 46 mmol/1 and thus helps to
reduce the inhibitory effect of the perchloric acid. The
use of end-point methods for all seven metabolites
would overcome the problems of perchloric acid but
this would mean much longer incubation times and
the use of much higher concentrations of enzymes
making the assays correspondingly slower and more
expensive.
Hansen & Freier (19) have described methods for
assay of the lactate, pyruvate, 3-hydroxybutyrate and
acetoacetate concentrations of plasma using a spec-
trophotometric centrifugal fast analyser. Our fluori-
metric techniques allow lower concentrations of these
metabolites to be measured with improved precision.
For example with 3-hydroxybutyrate the spectropho-
tometric analyser gave between batch imprecision of
10% at 44 μιηοΐ/ΐ (20) whereas we found 4.5% at 12
μηιοΐ/ΐ and 1.0% at 93 μηκ>1/1.
The intra-assay precision was the worst for the esti-
mation of lactate. This probably reflects the use of a
"two-point" assay, the reaction not having gone to
completion, and the instrument's own programs for
data calculation from non-linear standard curves.
Only the glucose and lactate assays require these
programs, the other assays providing linear standard
curves. Inter-assay precision for most analyses was
excellent. Inter-assay precision studies were not car-
ried out for acetoacetate analysis because of the inst-
ability
 aof this metabolite in low concentration espe-
cially in solutions containing even sjp ll amounts of
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protein. Overall precision was at least as good as
obtained by other methods and at the higher concen-
trations much better.
Excellent correlation was obtained between the values
obtained with the continuous flow and centrifugal
fast analysers and apart from the acetoacetate and
glycerol assays the slope of the regression line was
close to unity. For acetoacetate the explanation of
this deviation may lie in the inherent instability of
this metabolite but for glycerol may lie in the calcu-
lation procedure. Glycerol is analysed using a rate-
reaction method but the calibration curve shows sig-
nificant curvature suggesting sub-optimal conditions.
In relation to this assay it is important that the enzyme
reagent is freshly prepared and pre-warmed to 25 °C
before use.
Regression analysis showed positive intercepts for
alanine and glycerol but these were small in relation
to the levels usually found in blood. The negative
intercept for the lactate assay is also small in relation
to usual blood levels. The reason for these intercepts
is unclear but again may be due to the calculation
procedures used by the microprocessor in the Cobas
Bio to calculate the substrate concentrations. For
acetoacetate the correlation against a manual spec-
trophotometric method (7) as a satisfactory continu-
ous-flow method is unavailable.
One disadvantage of the continuous-flow methods is
the need for two autoanalyser "runs" to be made: one
to determine the concentration of the substrate pres-
ent, and the other to determine the instrinsic or
"blank" fluorescence in the blood extracts. This
"blank" can range from the barely detectable to
amounts above the top standard in the range used.
Another disadvantage with the continuous-flow meth-
ods is the need to draw calibration graphs and com-
pare large numbers of peaks which is necessarily time-
consuming and a notorious source of error. The tecU
ium of the analyst and the calculation errors can be
very much reduced by using an appropriate program
and a microcomputer to process the fluorimeter data
(20). A major advantage of the Cobas Bio analyser
is that the instrument automatically takes sample
blanks into account thus eliminating "blank" runs.
This results in a very considerable saving of time and
reagents so that analysis of batches of all six metab-
olites takes less than half the time used with the
continuous-flow methods. Measuring acetoacetate by
the Cobas Bio analyser is very much quicker than the
manual or automated spectrophotometric methods
previously described (7 — 12).
The fluorimetric methods we have described are ex-
tremely sensitive and readily assay as little as 100
pmol of pyruvate, 200 pmol of 3-hydroxybutyrate
and 400 pmol of glycerol. There is, generally, enough
glucose and lactate in our samples for much less
sensitive methods to be used. However, to eliminate
an extra source of error the methods have been de-
signed so that the whole group of analyses can be
done without further dilution of the intial perchloric
acid extract. The volume of perchloric acid extract
needed to carry out all seven analyses is about 100 μΐ
which represents 20 μΐ or less of blood and is much
less than that required for the continuous-flow system.
By using less sample, reagent costs including partic-
ularly expensive enzyme preparations is approxi-
mately one third of those needed for the continuous-
flow system. Operation of the Cobas Bio, however,
does require the use of disposable rotors and the cost
of these makes analysis only about 20% less expensive
overall than the continuous-flow system. The use of
small samples entails an increased possibility that end-
point analyses are feasible.
With the Cobas Bio, a change from one metabolite
method to another can be made very quickly. There-
fore it is possible to analyse small numbers of samples
for a variety of different metabolites quickly, whereas
the continuous-flow system is most economical of
time and reagents when relatively long "runs" are
made. Thus the Cobas Bio allows greater flexibility
in the choice of the methods available as well as being
more user-friendly. In practice we have found that
analysts become proficient in the use of the Cobas
Bio in a very much shorter time than that necessary
with the continuous-flow system.
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